POLYPEPTIDE AND USE THEREOF IN REGULATING BLOOD GLUCOSE LEVEL AND/OR REDUCING FAT
Number of patents in Portfolio can not be more than 2000
United States of America
Stats
-
N/A
Issued Date -
Apr 3, 2025
app pub date -
Sep 24, 2024
filing date -
Sep 24, 2024
priority date (Note) -
Published
status (Latency Note)
Importance
Abstract
A polypeptide and a use thereof in regulating blood glucose level and/or reducing fat are disclosed. The amino acid sequence of the polypeptide includes the sequence of SEQ ID No.: 1, the sequence of SEQ ID No.: 2, the sequence of SEQ ID No.: 3, the sequence of SEQ ID No.: 4, or a sequence obtained by modifying at least one amino acid in any of the aforesaid sequences. The polypeptide disclosed herein has the physiological activity to enhance fat metabolism and regulate blood glucose level. Therefore, administering an effective amount of the polypeptide, or a composition containing the polypeptide, to an individual can effectively produce the effect of treating or preventing a disease related to blood glucose imbalance or to imbalance in fat metabolism.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully